Dear colleagues,
Gunnar Kahlmeter explains the role of EUCAST’s antimicrobial susceptibility breakpoints for the fight against resistance in an article in Pharmtech.
Other publications of interest are the UK’s review on Antimicrobial Resistance where the final report outlines the issues and recommendations. And the European Medicines Agency also published its 2015 annual report, which focuses on the agency’s core tasks: evaluation of medicines, support to R&D of new treatments and monitoring of benefits and risks of medicines.
Best regards, your ESCMID communications editors